Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03986645
Other study ID # CIV-16-11-017784
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2016
Est. completion date September 30, 2018

Study information

Verified date June 2019
Source University Children's Hospital, Zurich
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Assess the accuracy of 4D flow cardiac MRI to measure blood flow and velocity, delineate 3D cardiac anatomy and visualize flow dynamics using two (2) different pulse sequences.


Description:

Advances in pediatric (cardiac) surgery, interventional techniques and medical care have improved survival for children born with congenital heart disease. Assessment of blood flow and pressures within the heart plays an integral role in the management of patients with congenital or acquired structural heart disease aiding with diagnoses, surveillance for complications, in relation to surgical or catheter procedures, and for therapeutic decision making. Current gold standard, direct intracardiac measurement of flow and pressures is an invasive procedure, while non-invasive echography-Doppler is limited by poor acoustic windows and operator dependency.

Therefore, cardiac MRI (cMRI) has been recommended as an important alternative in imaging of pediatric heart disease. Current clinical standard for MR flow imaging is 2-dimensional providing flow in a single cross-sectional plane. Current clinical CMR protocols in pediatric congenital heart disease are time consuming, depend on technician's experience and require direct supervision by an experienced cardiovascular imaging specialist. 4D Flow is a new approach for cMRI that might overcome these disadvantages. It allows scanning of the entire chest in approximately 7 minutes (depending on field of view, heart rate and resolution). The images can be off-line reconstructed in any plane, avoiding the need to precisely define crosssectional planes during acquisition for each vessel. Owing to time resolved visualizations of intracardiac flow dynamics occult jets or dynamic jets might be more likely to be detected. Potential disadvantages, rsp. potential advantages to be confirmed include lower temporal resolution of 4D sequences than current 2D sequences, unknown consequences of gradient artefacts induced by new velocity encoding schemes and diagnostic plausibility of disease related image features .


Recruitment information / eligibility

Status Completed
Enrollment 8
Est. completion date September 30, 2018
Est. primary completion date September 30, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria Patients:

- Clinical referral for cMRI in the absence of any contraindication to cMRI

- Flow measurements are part of the clinical cMRI protocol

- Signed informed consent of participants and/or legal representatives according to current ethical rules and regulations for children and adults

- For females in reproductive age, exclusion of pregnancy by a pregnancy test conducted before the cMRI

Exclusion Criteria Patients:

- Any contraindication for undergoing a cMRI examination or for receiving gadolinium contrast media (renal failure, allergy) per internal institutional policy of University Children's Hospital Zurich

- Any intrathoracic device causing imaging artifacts

- Medical condition at time of examination that would make additional study-related MR scans an unjustified burden or risk.

- Inability or unwillingness to provide informed consent.

Inclusion Criteria Healthy Controls:

- Absence of any contraindication to cMRI

- Signed informed consent of participants according to current ethical rules and regulations

- For females in reproductive age, exclusion of pregnancy by a pregnancy test conducted before the cMRI.

Exclusion Criteria Healthy Controls:

- Any contraindication for undergoing a cMRI examination per internal institutional policy of University Children's Hospital Zurich

Study Design


Related Conditions & MeSH terms


Intervention

Device:
MR data acquisition
MR data acquisition using CE and non-CE marked pulse sequences.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Emanuela Valsangiacomo

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of data processing Comparison of flow velocities and blood flow measured by 4D flow cMRI pulse sequences against phantom corrected 2D cMRI data. Within 72 hours after completion of exam
Secondary Image quality Qualitative grading of 4D flow cMRI anatomical images for image quality using a numerical scale. Within 72 hours after completion of exam
Secondary Comparability Qualitative grading of comparability of anatomical findings in 4D flow cMRI anatomical images with contrast-enhanced MR angiography images, if these have been acquired during the clinical examination of patients, using a numerical scale. Within 72 hours after completion of exam
Secondary Clinical value Qualitative grading of clinical and diagnostic value of visualizations of flow dynamics using a numerical scale. Within 72 hours after completion of exam
See also
  Status Clinical Trial Phase
Recruiting NCT05429060 - A Prospective Evaluation of Hemorrhoidal Surgery Outcome in Istanbul
Recruiting NCT05995925 - Observational Study for Perioperative Care of Patients Requiring ICU (OPICU)